NCT00093704 2020-07-31Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive LymphomaJonsson Comprehensive Cancer CenterPhase 1 Terminated1 enrolled
NCT00716911 2015-06-08Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell TransplantCity of Hope Medical CenterPhase NA Completed100 enrolled
NCT00006340 2013-07-26Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr VirusBoston Medical CenterPhase 1 Completed